These findings indicate that HDAC inhibitors greatly enhance the antitumor effect of mTORkis, suggesting that combined inhibition of HDAC and mTOR may be an effective therapeutic strategy in cancers that overexpress Snail with decreased 4E-BP1 expression. This evidence concerns the gene EIF4EBP1 and cancer.